{"id":897,"date":"2014-01-10T17:52:22","date_gmt":"2014-01-10T09:52:22","guid":{"rendered":"http:\/\/192.168.6.218\/?p=897"},"modified":"2026-07-22T14:15:49","modified_gmt":"2026-07-22T06:15:49","slug":"1-3-2","status":"publish","type":"post","link":"https:\/\/www.trx.com.tw\/en\/1-3-2\/","title":{"rendered":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year."},"content":{"rendered":"<p class=\"wp-block-paragraph\">MoneyDJ<\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.aspx?a=058f83d3-932f-4c49-8593-3f4d895f7c24#ixzz2qSZZmRmQ\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.aspx?a=058f83d3-932f-4c49-8593-3f4d895f7c24#ixzz2qSZZmRmQ<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>MoneyDJ<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"wp-custom-template-7","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-897","post","type-post","status-publish","format-standard","hentry","category-new-en"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5 - aioseo.com -->\n\t<meta name=\"description\" content=\"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp\" \/>\n\t<meta name=\"robots\" content=\"noindex, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<meta name=\"author\" content=\"Dino\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.trx.com.tw\/en\/1-3-2\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.\" \/>\n\t\t<meta property=\"og:description\" content=\"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.trx.com.tw\/en\/1-3-2\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-01-10T09:52:22+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-07-22T06:15:49+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/good.sehouse\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.\" \/>\n\t\t<meta name=\"twitter:description\" content=\"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#blogposting\",\"name\":\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"headline\":\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.\",\"author\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/author\\\/dinochueh\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\\u53f0\\u777f-\\u4e2d\\u6587LOGO-keyer-effects-358x125-1.png\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#articleImage\",\"width\":358,\"height\":125},\"datePublished\":\"2014-01-10T17:52:22+08:00\",\"dateModified\":\"2026-07-22T14:15:49+08:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#webpage\"},\"articleSection\":\"News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/category\\\/new-en\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/category\\\/new-en\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/category\\\/new-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#listItem\",\"name\":\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#listItem\",\"position\":3,\"name\":\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/category\\\/new-en\\\/#listItem\",\"name\":\"News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#organization\",\"name\":\"\\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"description\":\"\\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/\\u53f0\\u777f-\\u4e2d\\u6587LOGO-keyer-effects-358x125-1.png\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#organizationLogo\",\"width\":358,\"height\":125},\"image\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/good.sehouse\\\/\",\"https:\\\/\\\/www.instagram.com\\\/good.sehouse\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@-good.sehouse\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/author\\\/dinochueh\\\/#author\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/author\\\/dinochueh\\\/\",\"name\":\"Dino\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3c13c412fc28e364595f58e64f1d45e3064ebaf748c5ab4610095d29d3a1c1c7?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Dino\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#webpage\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/\",\"name\":\"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"description\":\"MoneyDJ http:\\\/\\\/www.moneydj.com\\\/KMDJ\\\/News\\\/NewsViewer.asp\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/1-3-2\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/author\\\/dinochueh\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/author\\\/dinochueh\\\/#author\"},\"datePublished\":\"2014-01-10T17:52:22+08:00\",\"dateModified\":\"2026-07-22T14:15:49+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/\",\"name\":\"\\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"alternateName\":\"\\u53f0\\u777f\\u751f\\u6280\",\"description\":\"\\u65b0\\u85e5\\u7814\\u767c\\u516c\\u53f8 | \\u53f0\\u777f\\u751f\\u6280 New Drug Development | TaiRx, Inc.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.trx.com.tw\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","description":"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp","canonical_url":"https:\/\/www.trx.com.tw\/en\/1-3-2\/","robots":"noindex, max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#blogposting","name":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","headline":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.","author":{"@id":"https:\/\/www.trx.com.tw\/en\/author\/dinochueh\/#author"},"publisher":{"@id":"https:\/\/www.trx.com.tw\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.trx.com.tw\/wp-content\/uploads\/2026\/06\/\u53f0\u777f-\u4e2d\u6587LOGO-keyer-effects-358x125-1.png","@id":"https:\/\/www.trx.com.tw\/en\/#articleImage","width":358,"height":125},"datePublished":"2014-01-10T17:52:22+08:00","dateModified":"2026-07-22T14:15:49+08:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#webpage"},"isPartOf":{"@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#webpage"},"articleSection":"News"},{"@type":"BreadcrumbList","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/www.trx.com.tw\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/category\/new-en\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/category\/new-en\/#listItem","position":2,"name":"News","item":"https:\/\/www.trx.com.tw\/en\/category\/new-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#listItem","name":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year."},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#listItem","position":3,"name":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.","previousItem":{"@type":"ListItem","@id":"https:\/\/www.trx.com.tw\/en\/category\/new-en\/#listItem","name":"News"}}]},{"@type":"Organization","@id":"https:\/\/www.trx.com.tw\/en\/#organization","name":"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","description":"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","url":"https:\/\/www.trx.com.tw\/en\/","logo":{"@type":"ImageObject","url":"https:\/\/www.trx.com.tw\/wp-content\/uploads\/2026\/06\/\u53f0\u777f-\u4e2d\u6587LOGO-keyer-effects-358x125-1.png","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#organizationLogo","width":358,"height":125},"image":{"@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/good.sehouse\/","https:\/\/www.instagram.com\/good.sehouse\/","https:\/\/www.youtube.com\/@-good.sehouse"]},{"@type":"Person","@id":"https:\/\/www.trx.com.tw\/en\/author\/dinochueh\/#author","url":"https:\/\/www.trx.com.tw\/en\/author\/dinochueh\/","name":"Dino","image":{"@type":"ImageObject","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/3c13c412fc28e364595f58e64f1d45e3064ebaf748c5ab4610095d29d3a1c1c7?s=96&d=mm&r=g","width":96,"height":96,"caption":"Dino"}},{"@type":"WebPage","@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#webpage","url":"https:\/\/www.trx.com.tw\/en\/1-3-2\/","name":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","description":"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.trx.com.tw\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.trx.com.tw\/en\/1-3-2\/#breadcrumblist"},"author":{"@id":"https:\/\/www.trx.com.tw\/en\/author\/dinochueh\/#author"},"creator":{"@id":"https:\/\/www.trx.com.tw\/en\/author\/dinochueh\/#author"},"datePublished":"2014-01-10T17:52:22+08:00","dateModified":"2026-07-22T14:15:49+08:00"},{"@type":"WebSite","@id":"https:\/\/www.trx.com.tw\/en\/#website","url":"https:\/\/www.trx.com.tw\/en\/","name":"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","alternateName":"\u53f0\u777f\u751f\u6280","description":"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.trx.com.tw\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"\u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","og:type":"article","og:title":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","og:description":"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp","og:url":"https:\/\/www.trx.com.tw\/en\/1-3-2\/","article:published_time":"2014-01-10T09:52:22+00:00","article:modified_time":"2026-07-22T06:15:49+00:00","article:publisher":"https:\/\/www.facebook.com\/good.sehouse\/","twitter:card":"summary_large_image","twitter:title":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. - \u65b0\u85e5\u7814\u767c\u516c\u53f8 | \u53f0\u777f\u751f\u6280 New Drug Development | TaiRx, Inc.","twitter:description":"MoneyDJ http:\/\/www.moneydj.com\/KMDJ\/News\/NewsViewer.asp"},"aioseo_meta_data":{"post_id":"897","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-09-24 00:58:01","updated":"2026-09-24 00:58:01","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.trx.com.tw\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.trx.com.tw\/en\/category\/new-en\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.trx.com.tw\/en\/"},{"label":"News","link":"https:\/\/www.trx.com.tw\/en\/category\/new-en\/"},{"label":"TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.","link":"https:\/\/www.trx.com.tw\/en\/1-3-2\/"}],"_links":{"self":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/comments?post=897"}],"version-history":[{"count":0,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/897\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/media?parent=897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/categories?post=897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/tags?post=897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}